A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. REUTERS/Yves Herman Acquire Licensing Rights Aug 28 (Reuters) – Catalent Inc (CTLT.N) is close to reaching a settlement with activist investor Elliott Investment Management which will include new directors and a pledge to review strategic alternatives such as the …
Read More »Exclusive: Catalent to settle with Elliott, explore options -sources
